CompletedPHASE1, PHASE2NCT00851435

Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa

Studying Pneumonia caused by Pseudomonas aeruginosa infection

Last synced from ClinicalTrials.gov May 17, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Kenta Biotech Ltd
Principal Investigator: Violetta Georgescu
Kenta Biotech Ltd
Intervention: KBPA-101(biological)
Enrollment: 15 enrolled
Eligibility: 18 years · All sexes
Timeline: 2008 – 2009

Study locations (1)

Several sites in Switzerland, France, Belgium and Greece, Basel, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00851435 on ClinicalTrials.gov

Other trials for Pneumonia caused by Pseudomonas aeruginosa infection

Additional recruiting or active studies for the same condition.

RECRUITINGNCT03044223
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis
University of Ulm

See all trials for Pneumonia caused by Pseudomonas aeruginosa infection →

← Back to all trials